Authors:
Glicklich, D
Burris, L
Urban, A
Tellis, V
Greenstein, S
Schechner, R
Devarajan, P
Croizat, H
Citation: D. Glicklich et al., Angiotensin-converting enzyme inhibition induces apoptosis in erythroid precursors and affects insulin-like growth factor-1 in posttransplantation erythrocytosis, J AM S NEPH, 12(9), 2001, pp. 1958-1964
Authors:
Swiatecka-Urban, A
Garcia, C
Feuerstein, D
Suzuki, S
Devarajan, P
Schechner, R
Greenstein, S
Tellis, V
Kaskel, F
Citation: A. Swiatecka-urban et al., Basiliximab induction improves the outcome of renal transplants in children and adolescents, PED NEPHROL, 16(9), 2001, pp. 693-696
Authors:
Hartnick, CJ
Smith, RV
Tellis, V
Greenstein, S
Ruben, RJ
Citation: Cj. Hartnick et al., Reversible sensorineural hearing loss following administration of muromonab-CD3 (OKT3) for cadaveric renal transplant immunosuppression, ANN OTOL RH, 109(1), 2000, pp. 45-47
Authors:
Glicklich, D
Kapoian, T
Mian, H
Greenstein, S
Tellis, V
Croizat, H
Citation: D. Glicklich et al., Studies of erythroid burst-forming units in patients with posttransplant erythrocytosis, TRANSPLAN P, 31(1-2), 1999, pp. 1284-1285
Authors:
Glicklich, D
Kapoian, T
Mian, H
Gilman, J
Tellis, V
Croizat, H
Citation: D. Glicklich et al., Effects of erythropoietin, angiotensin II, and angiotensin-converting enzyme inhibitor on erythroid precursors in patients with posttransplantation erythrocytosis, TRANSPLANT, 68(1), 1999, pp. 62-66
Authors:
Glicklich, D
Thung, SN
Kapoian, T
Tellis, V
Reinus, JF
Citation: D. Glicklich et al., Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients, AM J GASTRO, 94(1), 1999, pp. 159-163